ICP 監測設備市場：規模、佔有率、法規、報銷、程序及 2036 年各細分市場預測

ICP 監測設備是一種醫療儀器，用於測量因神經系統疾病導致腦內壓力升高的患者的顱內壓 (ICP)。這些神經系統疾病包括創傷性腦損傷、蜘蛛網膜下腔出血、腦積水、腦瘤等。監測 ICP 非常重要，因為腦內壓力升高會導致腦損傷和其他嚴重併發症。

創傷性腦損傷 (TBI) 是使用 ICP 監測設備的主要原因。使用 EVD 進行 ICP 監測被視為黃金標準，因為它提供了 CSF 引流的附加治療功能。使用 EVD 進行 ICP 監測的一個阻礙因素是，對於腦室較小或腦腫脹的患者，插入 EVD 比較困難。此外，長時間使用 EVD 進行 ICP 監測會增加顱內感染的風險。

本報告對全球 ICP 監測設備市場進行了詳細分析，包括競爭格局、 SWOT 分析、 2036 年市場預測、區域和國家趨勢。

目錄

目前可用的 ICP 監控設備及競爭格局

• 洞察關鍵產業趨勢
• 2015 年至 2036 年 ICP 監測設備各細分市場總收入及市場預測
• 有關單位數量、平均售價和市場價值的詳細數據

全球、區域與國家洞察

• ICP 監測設備市場的 SWOT 分析
• ICP 監控設備市場的競爭動態洞察與趨勢
• 各國衛生系統概覽
• 特定國家的報銷政策
• 各國醫療科技法規

ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

ICP monitoring devices are medical devices used to measure intracranial pressure (ICP) in patients with neurological conditions that can cause increased pressure in the brain. These neurological conditions may include traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and brain tumors. Monitoring ICP is important because increased pressure in the brain can lead to brain damage and other serious complications.

Traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. ICP monitoring using an EVD is considered as the gold standard as the technique allows an additional therapeutic function of CSF drainage. One factor which limits the use of EVDs for ICP monitoring is the difficulty of inserting the device in patients with small ventricle size or in patients with brain swelling. Also, long term use of EVDs for ICP monitoring increases the risk of intracranial infection.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ICP Monitoring Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total ICP Monitoring Devices market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for ICP Monitoring Devices market.
• Competitive dynamics insights and trends provided for ICP Monitoring Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, Medtronic Plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, HpBio Proteses Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ICP Monitoring Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving ICP Monitoring Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ICP Monitoring Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ICP Monitoring Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.